ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LIPO Lipella Pharmaceuticals Inc

0.643
-0.0369 (-5.43%)
18 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 33k118k107k104k121k146k
Operating Income -736k-1.09M-1.57M-1.36M-730k-1.22M
Pre Tax Income -738k-1.07M-1.54M-1.32M-689k-1.19M
Net Income -738k-1.07M-1.54M-1.32M-689k-1.19M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) 000000
EBIT -737k-1.09M-1.57M-1.36M-730k-1.22M
EBITDA -736k-1.09M-1.57M-1.36M-729k-1.22M
Year End 31 December 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 962k259k184k450k
Operating Income -57k-1.92M-2.59M-4.75M
Pre Tax Income -62k-1.87M-2.6M-4.62M
Net Income -62k-1.87M-2.6M-4.62M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.011-0.193-0.269-0.796
EBIT -57k-1.86M-2.59M-4.75M
EBITDA -57k-1.92M-2.59M-4.74M